Reference
[Please submit your publication]
|
Tiwari P, Kumar A, Das RN, Malhotra V, VijayRaghavan K. A Tendon Cell Specific RNAi Screen Reveals Novel Candidates Essential for Muscle Tendon Interaction. PLoS One (2015) 10(10) e0140976
[
PubMed ID = 26488612
]
[
RRC reference
]
Rauskolb C, Pan G, Reddy BV, Oh H, Irvine KD. Zyxin links fat signaling to the hippo pathway. PLoS Biol (2011) 9(6) e1000624
[
PubMed ID = 21666802
]
[
RRC reference
]
|
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
100 |
482 |
0 |
0 |
0 |
NM_135063.1 |
CG5828-RA (CG5828), mRNA |
0 |
0 |
2 |
4 |
3 |
NM_132032.1 |
CG15769-RA (CG15769), mRNA |
0 |
0 |
2 |
3 |
3 |
NM_138132.1 |
CG9083-RA (CG9083), mRNA |
0 |
0 |
2 |
3 |
3 |
NM_206004.1 |
CG10719-RC, transcript variant C (brat), mRNA |
0 |
0 |
2 |
3 |
3 |
NM_134302.1 |
CG10719-RB, transcript variant B (brat), mRNA |
0 |
0 |
2 |
3 |
3 |
NM_057597.2 |
CG10719-RA, transcript variant A (brat), mRNA |
0 |
0 |
2 |
3 |
2 |
NM_205952.1 |
CG4128-RD, transcript variant D (nAcRalpha-30D), mRNA |
0 |
0 |
2 |
3 |
2 |
NM_205953.1 |
CG4128-RE, transcript variant E (nAcRalpha-30D), mRNA |
0 |
0 |
2 |
3 |
2 |
NM_164874.2 |
CG4128-RA, transcript variant A (nAcRalpha-30D), mRNA |
0 |
0 |
2 |
3 |
2 |
NM_205951.1 |
CG4128-RB, transcript variant B (nAcRalpha-30D), mRNA |
0 |
0 |
2 |
3 |
2 |
NM_135472.4 |
CG4128-RC, transcript variant C (nAcRalpha-30D), mRNA |
0 |
0 |
2 |
2 |
2 |
NM_132771.1 |
CG15027-RA (CG15027), mRNA |
0 |
0 |
1 |
6 |
8 |
NM_176694.1 |
CG3126-RB, transcript variant B (C3G), mRNA |
0 |
0 |
1 |
6 |
8 |
NM_132122.2 |
CG3126-RA, transcript variant A (C3G), mRNA |
0 |
0 |
1 |
5 |
3 |
NM_142945.2 |
CG13604-RA (CG13604), mRNA |
0 |
0 |
1 |
4 |
4 |
NM_137987.2 |
CG5539-RA (CG5539), mRNA |
0 |
0 |
1 |
4 |
3 |
NM_137130.2 |
CG10131-RA (CG10131), mRNA |
0 |
0 |
1 |
4 |
3 |
NM_167259.1 |
CG1615-RA, transcript variant A (Ork1), mRNA |
0 |
0 |
1 |
4 |
3 |
NM_078557.4 |
CG1615-RB, transcript variant B (Ork1), mRNA |
0 |
0 |
1 |
3 |
6 |
NM_130610.1 |
CG3600-RA (CG3600), mRNA |
0 |
0 |
1 |
3 |
3 |
NM_079411.2 |
CG7347-RA (mus304), mRNA |
0 |
0 |
1 |
2 |
10 |
NM_132074.1 |
CG3585-RA (CG3585), mRNA |
0 |
0 |
1 |
2 |
7 |
NM_168841.1 |
CG32226-RA (CG32226), mRNA |
0 |
0 |
1 |
2 |
7 |
NM_168794.2 |
CG32206-RB, transcript variant B (CG32206), mRNA |
0 |
0 |
1 |
2 |
7 |
NM_176360.1 |
CG32206-RC, transcript variant C (CG32206), mRNA |
0 |
0 |
1 |
2 |
6 |
NM_057841.3 |
CG5102-RA (da), mRNA |
0 |
0 |
1 |
2 |
3 |
NM_001031867.1 |
CG33950-RF, transcript variant F (trol), mRNA |
0 |
0 |
1 |
2 |
3 |
NM_144357.2 |
CG13475-RA (HGTX), mRNA |
0 |
0 |
1 |
2 |
2 |
NM_001031862.1 |
CG33950-RC, transcript variant C (trol), mRNA |
0 |
0 |
1 |
2 |
2 |
NM_001031865.1 |
CG33950-RB, transcript variant B (trol), mRNA |
|